Back to Results
First PageMeta Content
Retinoids / Carboxylic acids / Acute leukemia / Myeloid leukemia / Bexarotene / Retinoic acid / Tretinoin / Acute promyelocytic leukemia / Targeted therapy / Medicine / Oncology / Biology


C o m m e n t a r y Investments in Cancer Research Is Now The Time for Continued
Add to Reading List

Document Date: 2012-02-01 13:39:41


Open Document

File Size: 95,13 KB

Share Result on Facebook

City

Strasbourg / New York / /

Company

New England Journal / Scientific Counselors / NCI ’s / /

Country

France / United States / /

Facility

Memorial Sloan-Kettering Cancer Center / Cornell University Medical College / Mt. Sinai Hospital / M.D. Anderson Cancer Center / Harvard College / Salk Institute / /

IndustryTerm

cancer therapy / /

MedicalCondition

leukemia / tumor / cancer / intramural cancer / mouse leukemia / lung cancer / acute promyelocytic leukemia / mouse erythroleukemia cells / nation’s cancer / lung cancers / about engineering mouse erythroleukemia cells / /

MedicalTreatment

ccr / cancer therapy / /

Organization

Board of Scientific Counselors for Clinical Sciences and Epidemiology / Pharmacology and Toxicology Department / Salk Institute in San Diego / Memorial Sloan-Kettering Cancer Center / American Cancer Society / Board of Scientific Counselors / National Academy of Sciences / Cornell University Medical College / Harvard College / Mt. Sinai Hospital in New York / Dartmouth Medical School / /

Person

Theodore Breitman / Ethan Dmitrovsky / Charlotte Friend / Pierre Chambon / Ronald Evans / /

Position

Professor / Professor and Chair / chair / scientist / /

Product

vitamin A / dimethyl sulfoxide / /

ProvinceOrState

California / /

PublishedMedium

Proceedings of the National Academy of Sciences / the New England Journal of Medicine / /

Technology

treating cancer / human genome / /

SocialTag